golimumab
janssen,merck
['golimumab', 'achieve,(-u achieve),(-u-achieve),(-uachieve)', 'axspa']
0545. at #acr22
continuing vs withdrawing from golimumab in nr-axspa who achieved inactive disease: efficacy &amp; safety results from a placebo-controlled, randomized withdrawal &amp; retreatment study go-back continued glm &gt; against disease flares compared to glm withdrawal 
Annals of the Rheumatic Diseases (#1 research journal in Rheumatology) & RMD Open are the official @EULAR_ORG journals. High quality, peer reviewed research.